MLD FOUNDATION Trademark

Trademark Overview

On Wednesday, May 15, 2024, a trademark application was filed for MLD FOUNDATION with the United States Patent and Trademark Office. The USPTO has given the MLD FOUNDATION trademark a serial number of 98553071. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, March 21, 2025. This trademark is owned by MLD Foundation. The MLD FOUNDATION trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting the interests of patients, families, researchers, clinicians, and policymakers affected by metachromatic leukodystrophy by means of public advocacy
mld foundation

General Information

Serial Number98553071
Word MarkMLD FOUNDATION
Filing DateWednesday, May 15, 2024
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, March 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkMETACHROMATIC LEUKODYSTROPHY FOUNDATION
Goods and ServicesPromoting the interests of patients, families, researchers, clinicians, and policymakers affected by metachromatic leukodystrophy by means of public advocacy

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code035
First Use Anywhere DateSunday, August 3, 2003
First Use In Commerce DateSaturday, January 19, 2008

Trademark Owner History

Party NameMLD Foundation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Linn, OR 97068

Trademark Events

Event DateEvent Description
Thursday, May 16, 2024NEW APPLICATION ENTERED
Monday, November 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 2, 2024ASSIGNED TO EXAMINER
Tuesday, December 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, December 3, 2024NON-FINAL ACTION E-MAILED
Friday, March 21, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 21, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Related Keywords

foundation leukodystrophy metachromatic means public advocacy affected policymakers patients interests families